HIV vaccine therapy
- 31 December 1991
- journal article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 13, 129-132
- https://doi.org/10.1016/0192-0561(91)90134-s
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Induction of CD4 + Human Cytolytic T Cells Specific for HIV-Infected Cells by a Gp160 Subunit VaccineScience, 1990
- Antigenic peptides recognized by T lymphocytes from AIDS viral envelope-immune humansNature, 1988
- CELLULAR ANTI-GP120 CYTOLYTIC REACTIVITIES IN HIV-1 SEROPOSITIVE INDIVIDUALSThe Lancet, 1988
- Second Conserved Domain of gp120 Is Important for HIV Infectivity and Antibody NeutralizationScience, 1988
- Long-Term Evaluation of HIV Antigen and Antibodies to p24 and gp41 in Patients with HemophiliaNew England Journal of Medicine, 1987
- HIV-specific cytotoxic T lymphocytes in seropositive individualsNature, 1987
- Anti-GP 120 Antibodies from HIV Seropositive Individuals Mediate Broadly Reactive Anti-HIV ADCCAIDS Research and Human Retroviruses, 1987
- HTLV-III-neutralizing antibodies in patients with AIDS and AIDS-related complexNature, 1985